Owkin to Build AI Agents as Part of a Multi-Year K Pro License Agreement with AstraZeneca
NEW YORK and PARIS, May 13, 2026 — Owkin today announced an agreement with AstraZeneca to build biopharma agents as part of their three-year licensing of K Pro – Owkin’s […] The post Owkin to Build AI Agents as Part of a Multi-Year K Pro License Agreement with AstraZeneca appeared first on AIwire.